TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
706,409
|
658,876
|
613,195 |
Earnings before taxes |
23,022
|
21,461
|
19,679 |
Total assets |
174,674
|
173,297
|
189,084 |
Current assets |
171,123
|
169,183
|
182,758 |
Current liabilities |
118,264
|
117,694
|
140,313 |
Equity capital |
56,410
|
55,289
|
47,829 |
- share capital |
14,888
|
14,965
|
13,753 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
31.9%
|
25.3% |
Turnover per employee |
9,419
|
8,785
|
8,176 |
Profit as a percentage of turnover |
3.3%
![]() |
3.3%
|
3.2% |
Return on assets (ROA) | |||
Current ratio |
144.7%
|
143.7%
|
130.3% |
Return on equity (ROE) |
40.8%
|
38.8%
|
41.1% |
Change turnover |
50,909
|
-8,365
|
5,736 |
Change turnover % |
8%
|
-1%
|
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.